A new report shows that the number of FDA approvals for cancer drugs has shot up in the last few decades. What’s behind the rise?
A wave of incoming anti-inflammatories and gene therapies that could make it big
The biggest case of fraud in biotech history is getting its day in the spotlight.
ADC BIO’s innovative technology is helping to usher in oncology’s new age of therapeutic agents